Cozzolino D J, Lamb D J
Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
Curr Urol Rep. 2000 Dec;1(4):262-5. doi: 10.1007/s11934-000-0005-5.
Although the process of spermatogenesis is relatively efficient and resistant to damage, male infertility can result from exposure to toxic agents such as chemotherapeutic regimes, radiation, or occupational exposures to chemicals. Other types of infertility may result from migratory defects or poor survival of primordial germ cells during development, abnormal repopulation of the tubules by spermatogonia during development, or low cellularity of the testis (hypospermatogenesis). Presently, there are no effective therapies available to treat these patients. Recent studies in animal models have demonstrated that isolated testicular germ cells collected from testes may be transplanted into sterile recipient mice to regenerate spermatogenesis. This technology will have widespread applications in efforts to manipulate the genome and produce transgenic offspring, to improve agricultural species, to enhance sperm production in endangered species, to improve our understanding of the control mechanisms regulating spermatogenesis, and to treat male infertility.
尽管精子发生过程相对高效且抗损伤,但男性不育可能源于接触化疗方案、辐射等有毒物质或职业性接触化学物质。其他类型的不育可能是由于发育过程中原始生殖细胞迁移缺陷或存活率低、发育过程中精原细胞对生精小管的再填充异常,或睾丸细胞数量少(生精作用低下)所致。目前,尚无有效的疗法来治疗这些患者。最近在动物模型中的研究表明,从睾丸收集的分离睾丸生殖细胞可移植到不育的受体小鼠体内以再生精子发生。这项技术将在操纵基因组和产生转基因后代、改良农业物种、提高濒危物种的精子产量、增进我们对调节精子发生的控制机制的理解以及治疗男性不育等方面有广泛应用。